Bionano Genomics Inc Sees to Have Reduced Annualized Non-Gaap Operating Expenses by About $65.0 to $75.0 Mln by Q1 2025
Bionano Genomics Inc預計到2025年第一季度已將年化非公認會計准則運營支出減少約6,500萬美元,至7,500萬美元
Bionano Genomics Inc Sees to Have Reduced Annualized Non-Gaap Operating Expenses by About $65.0 to $75.0 Mln by Q1 2025
Bionano Genomics Inc預計到2025年第一季度已將年化非公認會計准則運營支出減少約6,500萬美元,至7,500萬美元
使用瀏覽器的分享功能,分享給你的好友吧